کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1219980 | 967755 | 2012 | 23 صفحه PDF | دانلود رایگان |

There have been relatively few direct intervention trials of mushroom consumption in humans, although those that have been completed to date indicate that mushrooms and their extracts are generally well-tolerated with few, if any, side-effects. Immunomodulating and anti-tumor effects of mushrooms and their extracts appear to hold potential health benefits. These benefits are primarily due to their polysaccharide content, either in the form of beta-glucans or polysaccharide-protein complexes, which appear to exert their anti-tumorigenic effects by enhancement of cellular immunity via effects on the balance of T helper cell populations and induction of certain interleukins and interferon (IFN)-γ. This review summarizes the current knowledge on edible mushrooms and their components on health outcomes, with a focus on the evaluation of the evidence from human trials. Where information is available from such trials, the active compounds are identified and their proposed mechanisms are discussed.
► There have been relatively few direct intervention trials of mushroom consumption in humans.
► In human trials, mushrooms and their extracts have been generally well-tolerated with few, if any, side-effects.
► Immuno-modulating and anti-tumor effects of mushrooms and their extracts appear to hold potential health benefits.
► The most promising data are those indicating an inverse relationship between mushroom consumption and breast cancer risk.
Journal: Journal of Functional Foods - Volume 4, Issue 4, October 2012, Pages 687–709